Zhang Jiawei, Song Yijing, Li You, Lin Han-Bin, Fang Xuexian
Department of Nutrition and Toxicology, School of Public Health, Hangzhou Normal University, Hangzhou, China.
Zhongshan Institute for Drug Discovery, SIMM, CAS, Zhongshan, China; Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
J Mol Cell Cardiol. 2023 Jan;174:15-24. doi: 10.1016/j.yjmcc.2022.11.001. Epub 2022 Nov 11.
Iron is necessary for the life of practically all living things, yet it may also harm people toxically. Accordingly, humans and other mammals have evolved an effective and tightly regulatory system to maintain iron homeostasis in healthy tissues, including the heart. Iron deficiency is common in patients with heart failure, and is associated with worse prognosis in this population; while the prevalence of iron overload-related cardiovascular disorders is also increasing. Therefore, enhancing the therapy of patients with cardiovascular disorders requires a thorough understanding of iron homeostasis. Here, we give readers an overview of the fundamental mechanisms governing systemic iron homeostasis as well as the most recent knowledge about the intake, storage, use, and export of iron from the heart. Genetic mouse models used for investigation of iron metabolism in various in vivo scenarios are summarized and highlighted. We also go through different clinical conditions and therapeutic approaches that target cardiac iron dyshomeostasis. Finally, we conclude the review by outlining the present knowledge gaps and important open questions in this field in order to guide future research on cardiac iron metabolism.
铁对于几乎所有生物的生命都是必需的,但它也可能对人体产生毒性危害。因此,人类和其他哺乳动物已经进化出一种有效且严格调控的系统,以维持包括心脏在内的健康组织中的铁稳态。心力衰竭患者中铁缺乏很常见,并且与该人群中更差的预后相关;而铁过载相关心血管疾病的患病率也在增加。因此,加强心血管疾病患者的治疗需要对铁稳态有透彻的了解。在此,我们向读者概述了调控全身铁稳态的基本机制以及关于铁从心脏的摄取、储存、利用和输出的最新知识。总结并强调了用于研究各种体内情况下铁代谢的基因小鼠模型。我们还梳理了针对心脏铁稳态失调的不同临床情况和治疗方法。最后,我们通过概述该领域目前的知识空白和重要的未解决问题来结束本综述,以指导未来关于心脏铁代谢的研究。